Overview Financials News + Filings Key Docs Charts Ownership Insiders |
REPLIGEN CORP (RGEN)
|
Add to portfolio |
|
|
Price: |
$257.96
| | Metrics |
OS: |
55.6
|
M
| |
|
|
Market cap: |
$14.3
|
B
| |
|
|
Net cash:
|
$339
|
M
| |
$6.10
|
per share
|
EV:
|
$14
|
B
| | | |
| | | | | |
TTM Valuation | | | |
EBITDA
|
$239
|
M
| |
58.6
|
x EV/EBITDA
|
EBIT
|
|
| |
|
|
EPS |
| |
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
Revenues | 801.5 | 670.5 | 366.3 | 270.2 | 194.0 | 141.2 | 104.5 | 83.5 |
Revenue growth | 19.5% | 83.1% | 35.5% | 39.3% | 37.4% | 35.1% | 25.1% | 31.5% |
Cost of goods sold | 345.8 | 279.3 | 156.6 | 119.1 | 86.5 | 67.1 | 47.1 | 35.3 |
Gross profit | 455.7 | 391.3 | 209.6 | 151.1 | 107.5 | 74.2 | 57.4 | 48.3 |
Gross margin | 56.9% | 58.3% | 57.2% | 55.9% | 55.4% | 52.5% | 54.9% | 57.8% |
Selling, general and administrative | 215.8 | 183.9 | 119.6 | 95.6 | 65.7 | 51.5 | 30.9 | 24.7 |
Research and development | 43.9 | 34.3 | 20.2 | 19.5 | 15.8 | 8.7 | 7.4 | 5.7 |
EBITA | 251.8 | 189.3 | 85.9 | 49.7 | 36.6 | 20.2 | 21.3 | 19.4 |
EBITA margin | 31.4% | 28.2% | 23.5% | 18.4% | 18.9% | 14.3% | 20.4% | 23.3% |
Amortization of intangibles | 27.1 | 22.1 | 16.1 | 13.6 | 10.6 | 6.2 | 2.1 | 1.6 |
EBIT | 224.7 | 167.2 | 69.8 | 36.1 | 26.0 | 14.0 | 19.2 | 17.8 |
EBIT margin | 28.0% | 24.9% | 19.1% | 13.4% | 13.4% | 9.9% | 18.4% | 21.4% |
Pre-tax income | 219.1 | 153.5 | 59.2 | 26.2 | 21.4 | 7.2 | 11.7 | 13.4 |
Income taxes | 33.2 | 25.3 | -0.7 | 4.7 | 4.8 | -21.1 | 0.0 | 4.1 |
Tax rate | 15.1% | 16.4% | | 18.1% | 22.5% | | 0.1% | 30.4% |
Net income | 186.0 | 128.3 | 59.9 | 21.4 | 16.6 | 28.4 | 11.7 | 9.3 |
Net margin | 23.2% | 19.1% | 16.4% | 7.9% | 8.6% | 20.1% | 11.2% | 11.2% |
|
Diluted EPS | $3.24 | $2.24 | $1.11 | $0.44 | $0.37 | $0.72 | $0.34 | $0.28 |
Shares outstanding (diluted) | 57.5 | 57.3 | 53.9 | 49.2 | 45.5 | 39.2 | 34.1 | 33.6 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|